| 000 | 01486 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517184056.0 | ||
| 264 | 0 | _c20180205 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1178-2013 | ||
| 024 | 7 |
_a10.2147/IJN.S146978 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTong, Fei | |
| 245 | 0 | 0 |
_aQuercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium. _h[electronic resource] |
| 260 |
_bInternational journal of nanomedicine _c2017 |
||
| 300 |
_a7799-7813 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD11 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aEndothelium _xdrug effects |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aQuercetin _xadministration & dosage |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aLiu, Suhuan | |
| 700 | 1 | _aYan, Bing | |
| 700 | 1 | _aLi, Xuejun | |
| 700 | 1 | _aRuan, Shiwei | |
| 700 | 1 | _aYang, Shuyu | |
| 773 | 0 |
_tInternational journal of nanomedicine _gvol. 12 _gp. 7799-7813 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S146978 _zAvailable from publisher's website |
| 999 |
_c27774082 _d27774082 |
||